CPT code 64616 denotes a targeted chemical denervation procedure performed on unilateral neck muscles with avoidance of the laryngeal muscles to induce muscle paralysis. Clinically, it is used to treat conditions such as cervical dystonia and spasmodic torticollis, which produce sustained, often painful neck muscle contractions and abnormal head posture. The code matters nationally because these procedures affect neurologic and musculoskeletal specialty care pathways and have implications for outpatient surgical capacity and medical necessity determinations.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical indications tied to the code, the typical ambulatory settings in which the service is delivered, and commonly observed billing considerations. The publication also summarizes payer coverage patterns and benchmark perspectives where available, highlights relevant policy and coding updates that impact authorization and documentation requirements, and situates CPT code 64616 within clinical care workflows for movement disorder management.

Data not available in the input is noted where applicable.